Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous Thromboembolism
NCT01559207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-11-17
Summary
The main objective of this study is to evaluate, for 15 healthy volunteers and for 15 patients with a history of venous thromboembolism (VTE), the monthly variation (over 6 months) of plasma nucleosome and free DNA concentrations.
Conditions
- Venous Thromboembolism
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Nīmes
lead OTHER
Principal Investigators
-
Sylvie Bouvier, MD · Centre Hospitalier Universitaire de Nîmes
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2014-10-20
- Completion
- 2014-10-20
Countries
- France
Study Locations
More Related Trials
-
Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.
NCT01382550 ·Status: UNKNOWN
-
Prediction of Thrombosis Using D-dimer Trends in COVID-19
NCT04827160 ·Status: COMPLETED
-
Tumor-educated Platelets in Venous Thromboembolism
NCT02739867 ·Status: COMPLETED
-
Risk Factors for Venous Thromboembolism
NCT00018772 ·Status: COMPLETED
-
Genetic Epidemiology of Venous Thromboembolism
NCT00005543 ·Status: COMPLETED
-
Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women
NCT00745212 ·Status: COMPLETED
-
Cohort for Monitoring Patients With Venous Thromboembolic Disease
NCT07016542 ·Status: RECRUITING
-
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
NCT05301348 ·Status: RECRUITING ·Phase: NA
-
Epidemiology of Thromboembolism Disease: A Cohort Study
NCT00670540 ·Status: COMPLETED
-
Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With Cancer
NCT02407717 ·Status: COMPLETED
-
Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System)
NCT02892565 ·Status: COMPLETED ·Phase: NA
-
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
NCT02213978 ·Status: COMPLETED
-
Thrombin Generation Assay to Assess Thrombotic Risk in Nephrotic Patients
NCT05301829 ·Status: UNKNOWN
-
Effect of the Genotype on Postoperative DVT
NCT04940377 ·Status: COMPLETED
-
Incidence of Venous Thromboembolism and Professional Practices in Brest Area
NCT02895971 ·Status: COMPLETED
-
Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism
NCT00937820 ·Status: COMPLETED ·Phase: PHASE3
-
Incidence and Outcomes of Venous Thromboembolism
NCT00005351 ·Status: COMPLETED
-
Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)
NCT07119970 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT
NCT04297787 ·Status: COMPLETED ·Phase: NA
-
Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study
NCT06073366 ·Status: COMPLETED
-
Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin
NCT05819125 ·Status: TERMINATED
-
Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
NCT00788736 ·Status: COMPLETED
-
Effect of Aging on Haemostasis Parameters
NCT00299624 ·Status: COMPLETED
-
YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness
NCT01028950 ·Status: COMPLETED ·Phase: PHASE3
-
Deep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome
NCT04597138 ·Status: COMPLETED